Department of Neurology, Federal University of São Paulo, Rio de Janeiro, Brazil
Commentary
Bioavailability and bioequivalence of allopurinol in two tablet formulations
Author(s): Santif Gen*
Allopurinol is a compelling inhibitor of the catalyst xanthine oxidase, use for diminishing the blood centralizations
of urate and, in this manner, to diminish the amount of rehashed attacks of gout. Allopurinol is used to oxipurinol,
and hypouricaemic adequacy of allopurinol is expected in enormous part to this metabolite. .. View more»